Chronic poor sleep is associated with increased disease activity in patients with ulcerative colitis: Prospective observational study in Japan.

Inflammatory bowel disease Ulcerative colitis sleep disorder

Journal

Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676

Informations de publication

Date de publication:
25 Jul 2024
Historique:
received: 12 04 2024
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 25 7 2024
Statut: aheadofprint

Résumé

Although sleep disorders are associated with the pathogenesis of inflammatory bowel disease, the causal relationship is unclear. Therefore, in this study we aimed to clarify the causal relationship between them. We administered the Pittsburgh Sleep Questionnaire to participants during regular visits to evaluate their sleep condition and prospectively observed the participants. Participants were divided into poor sleep and non-poor sleep groups according to their first and second questionnaire scores. We compared inflammatory bowel disease relapse rates between the two groups. The study population included 139 patients with inflammatory bowel disease, including 60 with chronic poor sleep. Disease relapse rate was significantly higher in the poor sleep group than in the non-poor sleep group (28.3% vs. 8.9%; P=0.0033). Ulcerative colitis relapse rate was significantly higher in the poor sleep group than in the non-poor sleep group (34.5% vs. 10.3%, P=0.031). Multivariate analysis identified chronic poor sleep as a clinical factor that affected inflammatory bowel disease relapse (OR=6.69, 95% CI: 2.23-20.0, P=0.0007) and ulcerative colitis relapse (OR=8.89, 95% CI: 1.57-50.2, P=0.014). The Kaplan-Meier curve showed significantly lower cumulative treatment retention rates in the poor sleep group than in the non-poor sleep group (all patients, P=0.0061; ulcerative colitis, P=0.025). Concomitant chronic poor sleep may have a negative influence on the disease activity in patients with inflammatory bowel disease, especially in those with ulcerative colitis.

Sections du résumé

BACKGROUND AND AIM OBJECTIVE
Although sleep disorders are associated with the pathogenesis of inflammatory bowel disease, the causal relationship is unclear. Therefore, in this study we aimed to clarify the causal relationship between them.
METHODS METHODS
We administered the Pittsburgh Sleep Questionnaire to participants during regular visits to evaluate their sleep condition and prospectively observed the participants. Participants were divided into poor sleep and non-poor sleep groups according to their first and second questionnaire scores. We compared inflammatory bowel disease relapse rates between the two groups.
RESULTS RESULTS
The study population included 139 patients with inflammatory bowel disease, including 60 with chronic poor sleep. Disease relapse rate was significantly higher in the poor sleep group than in the non-poor sleep group (28.3% vs. 8.9%; P=0.0033). Ulcerative colitis relapse rate was significantly higher in the poor sleep group than in the non-poor sleep group (34.5% vs. 10.3%, P=0.031). Multivariate analysis identified chronic poor sleep as a clinical factor that affected inflammatory bowel disease relapse (OR=6.69, 95% CI: 2.23-20.0, P=0.0007) and ulcerative colitis relapse (OR=8.89, 95% CI: 1.57-50.2, P=0.014). The Kaplan-Meier curve showed significantly lower cumulative treatment retention rates in the poor sleep group than in the non-poor sleep group (all patients, P=0.0061; ulcerative colitis, P=0.025).
CONCLUSIONS CONCLUSIONS
Concomitant chronic poor sleep may have a negative influence on the disease activity in patients with inflammatory bowel disease, especially in those with ulcerative colitis.

Identifiants

pubmed: 39052880
pii: 7721050
doi: 10.1093/ecco-jcc/jjae116
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Hideaki Oyama (H)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Rintaro Moroi (R)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Atsushi Sakuma (A)

Department of Psychiatry, Tohoku University Hospital, Sendai, Japan.

Yusuke Shimoyama (Y)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Hiroshi Nagai (H)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Takeo Naito (T)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Hisashi Shiga (H)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Yoichi Kakuta (Y)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Yoshitaka Kinouchi (Y)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Atsushi Masamune (A)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Classifications MeSH